In April 2013, the EMR Standards Committee, constituted by the Ministry of Health & Family Welfare, and coordinated by the Federation of Indian Chambers of Commerce and Industry (FICCI), developed India’s first set of standards recommendations for the Government of India to adopt. http://clinicalestablishments.nic.in/WriteReadData/107.pdf
In this blog post, we will decipher the specific recommendations made, and the implications those recommendations will have for patients.
In order to develop these standards, the Committee worked with payers and providers, and studied EHR standards implemented successfully in 9 different countries (Australia, Austria, Canada, Denmark, England, Hong Kong, Netherlands, Singapore and Sweden). After thoroughly reviewing its recommendations, we found various path breaking recommendations in this report:
- The report defined all the fields that should be captured through the implementation of a minimum data set (MDS) that should be recorded for every individual patient. The recommendations were thorough – not only were the fields defined, but also the type of data (alphanumeric, numeric, text, etc.), the length of data, the format / values that should be captured, whether capturing the piece of data should be required or optional, and additional observations that ought to be recorded.
- The report recommended the use of the Unique ID, a nationwide unique identified program currently being implemented, as its basis of identifying individuals. In the absence of the availability of the number, the report provided vendors the option to capture any other unique identifiable information. This is a terrible strategy. The report should have defined a list of acceptable forms of unique identification, given the rampant prevalence of fake identification papers across India. As of March 2014, over 600 million people have been issued the Aadhar Unique ID. Having this healthcare system based on that as the Unique ID would have forced a greater adoption of the ID across those factions that haven’t yet enrolled in the program.
- The report-defined standards on capturing drugs administered, and based it on various internationally accepted drug-naming standards.
- The report stated that network and data security should be planned and implemented, yet was silent on best practices that need to be adopted to protect the data security. Given that the information being captured is sensitive personal information, inadequate stringency around data security may have undesirable consequences in the long run. Additionally, the language around data security and privacy was not as forceful, suggesting that this issue may not be taken this issue as seriously.
- The report did a great job of defining who owned the data (the patient) – this limits the ability of companies interested in building medical records systems for selling data to pharmaceutical companies without getting waivers first from patients or their next of kin (which may not be as difficult, given how little individuals read before signing off electronic waivers). The report clearly states that personal identifiable information (PII) will have to be excluded from such reports, and goes on to define the full list of fields that constitute PII.
- The report is silent on additional functionality that might be desirable for patients, including being able to access lab reports, make appointments, and buy prescription drugs. Given the lack of definition around acceptable norms, it may be hard for entrepreneurs to develop suitable technologies without running the risk of being thrown out of the market for not having complied at a later date.
- The report is also silent on next steps for the Government, and in particular how these recommendations need to be implemented.
The Government of India launched its first Electronic Health portal with advise for patients and end users in September 2013, and announced its set of Healthcare standards. Essentially, the standards announced were the same as those recommended by the FICCI report (to the extend that language / tables were copied verbatim).
What does this mean for the vendor community?
Having implemented a set of standards is a great first step for the Government to have taken. However, this isn’t sufficient. The next thing for the Government to do is to enforce the implementation and adoption at healthcare providers and payers by incentivizing adoption, similar to what we say with the successful implementation in Denmark. The Government could also potentially start implementation at Government hospitals, where the quality of care and service is often criticized in the press for being poor.
Entrepreneurs interested in this space have a choice – is this the right time to invest? Or do we need additional legislation and incentives for investment in this space? First-mover advantage and developing relationships with key medical establishments will enable successful implementation of EMR in India. The other choice entrepreneurs have is – whom will they target? Will high-end customers and medical institutions are a suitable customer? Are we interested in providing a service to everyone, and don’t really care about making profits?
Watch this space for exciting developments; India is at the cusp of a healthcare revolution that will likely transform the lives of a billion people for the better.